Latest Breaking News On - Medimmune astrazeneca - Page 4 : comparemela.com

Alpine Immune Sciences Appoints Jörn Drappa, MD, PhD, to Board of Directors

19.07.2022 - Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the appointment of Jörn Drappa, MD, PhD, to . Seite 1

Viela bioGenentech rocheMedimmune astrazenecaVentyx biosciencesUniversity of cologneChief medical officerHorizon therapeuticsNeuromyelitis opticaSpectrum disorderNew york presbyterian hospitalSpecial surgeryAlpine immune sciences

Alpine Immune Sciences (ALPN) Appoints Jorn Drappa to its Board

Alpine Immune Sciences (ALPN) Appoints Jorn Drappa to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Viela bioGenentech rocheMedimmune astrazenecaVentyx biosciencesJay venkatesanUniversity of cologneAlpine immune sciences incImmune sciencesExecutive chairmanChief executive officerChief medical officerHorizon therapeuticsNeuromyelitis optica spectrum disorderNew york presbyterian hospitalSpecial surgery

Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer

/PRNewswire/ Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today.

Bali muralidharPrnewswire anjarium biosciencesStephen yooMedimmune astrazenecaAnjarium biosciencesAbbott labsChief executive officerChief medical officerThird harmonic bioManaging partnerOmega fundsPfizer venturesSurveyor capital

BLOG: What are the ocular side effects of immune checkpoint inhibitors?

BLOG: What are the ocular side effects of immune checkpoint inhibitors?
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesRegeneron sanofiGenentech rocheMedimmune astrazenecaBristol myers squibbDoug rettGreater boston

STipe Therapeutics appoints Dr Richard Sainson as Chief Scientific Officer to Lead Research

AARHUS, Denmark, May 31, 2022 (GLOBE NEWSWIRE) STipe Therapeutics (STipe), a company with a novel approach to leverage the STimulator of INterferon Genes (STING) Pathway, a major driver of

New zealand generalNew zealandMarie curieClaus olesenRichard sainsonJulia wilsonMedimmune astrazenecaArix bioscienceUniversity of oxfordUniversity of california irvineAstex pharmaceuticalsKymab ltdJw communicationsUniversity of leedsWellington partners life sciencev fundNovo holdings